Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.